You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Baxter
McKinsey
Merck
McKesson

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

Patent: 10,208,115

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,208,115
Title:Amino acid sequences that modulate the interaction between cells of the immune system
Abstract: The present invention relates to amino acid sequences that block the interaction between (a target on) an antigen presenting cell (APC) and (a target on) a T-cell. More particularly, the present invention relates to amino acid sequences that are directed against (as defined herein) a target on an APC (also referred to herein as \"APC target\") or a target on a T-cell (also referred to herein as \"T-cell target\"). The invention further relates to compounds or constructs, and in particular proteins and polypeptides, that comprise or essentially consist of one or more such amino acid sequences.
Inventor(s): Hermans; Guy (Merelbeke, BE), Verheesen; Peter (Ghent, BE), Dolk; Edward (Utrecht, NL), Hoogenboom; Hendricus Renerus Jacobus Mattheus (Maastricht, NL), Saunders; Michael John Scott (Brussels, BE), De Haard; Hans (Oudelande, NL), de Bruin; Renee (Amsterdam, NL)
Assignee: Ablynx N.V. (Ghent-Zwijnaarde, BE)
Application Number:15/050,740
Patent Claims:see list of patent claims

Details for Patent 10,208,115

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Grifols Usa, Llc PLASBUMIN albumin (human) SOLUTION 101138 1 1994-09-26   Start Trial Ablynx N.V. (Ghent-Zwijnaarde, BE) 2026-12-15 search
Baxalta Us Inc. FLEXBUMIN albumin human INJECTION, SOLUTION 101452 1 2014-07-31   Start Trial Ablynx N.V. (Ghent-Zwijnaarde, BE) 2026-12-15 search
Csl Behring Ag ALBURX albumin (human) SOLUTION 102366 1 2009-01-06   Start Trial Ablynx N.V. (Ghent-Zwijnaarde, BE) 2026-12-15 search
Grifols Usa, Llc ALBUTEIN albumin (human) INJECTION, SOLUTION 102478 1 2019-12-15   Start Trial Ablynx N.V. (Ghent-Zwijnaarde, BE) 2026-12-15 search
Grifols Usa, Llc HUMAN ALBUMIN GRIFOLS albumin (human) SOLUTION 103352 1 2003-06-11   Start Trial Ablynx N.V. (Ghent-Zwijnaarde, BE) 2026-12-15 search
Csl Behring Llc ALBUMINAR-25 albumin (human) SOLUTION 103955 1 2009-01-06   Start Trial Ablynx N.V. (Ghent-Zwijnaarde, BE) 2026-12-15 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Baxter
Johnson and Johnson
McKinsey
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.